Vorsitz: H. Möllmann (Dortmund), D. Frank (Kiel)
(V879) | Impact of Myocardial Fibrosis on 10-Year-Outcome in Patients Undergoing Aortic Valve Replacement | |
B. Fries, F. Weidemann, K. Hu, D. Liu, J. Strotmann, P. Nordbeck, M. Beer, S. Gattenlöhner, S. Störk, W. Voelker, G. Ertl, S. Herrmann (Würzburg, Unna, Kiel, Ulm, Gießen) | ||
Diskussion | ||
(V880) | Long-term outcome after successful transcatheter mitral valve repair in surgical high-risk patients: 5-year results of a real-life cohort | |
E. P. Tigges, D. Kalbacher, C. Thomas, F. Deuschl, N. Schofer, D. Reichart, L. Conradi, J. Schirmer, U. Schäfer, H. Reichenspurner, S. Blankenberg, E. Lubos (Hamburg) | ||
Diskussion | ||
(V881) | One Year Outcome in Patients Undergoing Transfemoral Aortic Valve Replacement (TAVR) with the Repositionable and Retrievable Lotus Valve Compared with the Balloon-expandable Edwards Sapien 3 Device | |
J. Seeger, B. Gonska, W. Rottbauer, J. Wöhrle (Ulm) | ||
Diskussion | ||
(V882) | Multicenter propensity matched comparison of two novel transfemoral Transcatheter Heart Valves – ACURATE neo versus SAPIEN 3 | |
O. Husser, W.-K. Kim, C. Pellegrini, A. Holzamer, T. Walther, N. P. Mayr, M. Joner, M. Kasel, J. Michel, T. Trenkwalder, T. Rheude, A. Kastrati, H. Schunkert, C. Burgdorf, M. Hilker, H. Möllmann, C. Hengstenberg (München, Bad Nauheim, Regensburg, Bad Bevensen, Dortmund) | ||
Diskussion | ||
(V883) | Keynote Lecture: State of the Art | |
E. Schulz (Mainz) | ||
Diskussion |
17:45 - 19:45 | Eröffnung des Kongresses in Saal 4 |